XLID syndrome gene Med12 promotes Ig isotype switching through chromatin modification and enhancer RNA regulation

Sci Adv. 2022 Nov 25;8(47):eadd1466. doi: 10.1126/sciadv.add1466. Epub 2022 Nov 25.

Abstract

The transcriptional coactivator Med12 regulates gene expression through its kinase module. Here, we show a kinase module-independent function of Med12 in CSR. Med12 is essential for super-enhancer activation by collaborating with p300-Jmjd6/Carm1 coactivator complexes. Med12 loss decreases H3K27 acetylation and eRNA transcription with concomitant impairment of AID-induced DNA breaks, S-S synapse formation, and 3'RR-Eμ interaction. CRISPR-dCas9-mediated enhancer activation reestablishes the epigenomic and transcriptional hallmarks of the super-enhancer and fully restores the Med12 depletion defects. Moreover, 3'RR-derived eRNAs are critical for promoting S region epigenetic regulation, synapse formation, and recruitment of Med12 and AID to the IgH locus. We find that XLID syndrome-associated Med12 mutations are defective in both 3'RR eRNA transcription and CSR, suggesting that B and neuronal cells may have cell-specific super-enhancer dysfunctions. We conclude that Med12 is essential for IgH 3'RR activation/eRNA transcription and plays a central role in AID-induced antibody gene diversification and genomic instability in B cells.

MeSH terms

  • Chromatin / genetics
  • Epigenesis, Genetic
  • Humans
  • Immunoglobulin Class Switching*
  • Immunoglobulin Heavy Chains / genetics
  • Immunoglobulin Heavy Chains / metabolism
  • Immunoglobulin Isotypes*
  • Jumonji Domain-Containing Histone Demethylases / metabolism
  • Mediator Complex / genetics
  • Mediator Complex / metabolism
  • RNA
  • Syndrome
  • Transcription Factors / metabolism

Substances

  • Immunoglobulin Isotypes
  • RNA
  • Immunoglobulin Heavy Chains
  • Transcription Factors
  • Chromatin
  • MED12 protein, human
  • Mediator Complex
  • JMJD6 protein, human
  • Jumonji Domain-Containing Histone Demethylases